Adviye Ergul to Thromboembolism
This is a "connection" page, showing publications Adviye Ergul has written about Thromboembolism.
Connection Strength
0.252
-
Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab. 2019 08; 39(8):1635-1647.
Score: 0.142
-
Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol. 2015 Apr; 51(2):766-78.
Score: 0.110